News
2h
Zacks.com on MSNTempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 ReleaseTEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.
Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 healthcare AI stocks to buy according to hedge funds. On June 30, 2025, ...
17h
TipRanks on MSNTempus AI Announces $400 Million Convertible Notes OfferingMake smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.The latest update is out from Tempus AI, Inc. Class A ( (TEM) ). On June 30, 2025, Tempus AI ...
Tempus AI, Inc. ("Tempus") (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...
Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s ...
Tempus AI (NasdaqGS:TEM) recently saw its market presence elevated as it was added to multiple Russell indices, showcasing an enhanced visibility. The company also bolstered its strategic partnerships ...
Tempus AI's innovation in genomics, data, and applications makes the company well positioned to become a contender in the AI ...
Tempus AI Inc. (NASDAQ:TEM) is one of the best AI stocks to buy according to hedge funds. On June 25, Ambry Genetics, which ...
Law Offices of Howard G. Smith reminds investors of the upcoming August 12, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Tempus AI, Inc.
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Tempus AI, Inc. ("Tempus" or the "Company") (NASDAQ: TEM) common stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results